Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Agomelatine in Obsessive-Compulsive Disorder
NCT01108393Phase 2Completed
- Sponsor
- Servier
- Start
- May 2010
- Primary completion
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of agomelatine in obsessive compulsive disorder (OCD), sponsored by Servier. Started May 2010; status: completed.
02
Drugs
agomelatine
03
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on NCT01108393.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01108393.